GlassScriptPhysician profile
Lee R Leddy
NPI 1730365131
$896.01
in general payments reported to CMS, 2019-2025
11 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $208 · 2022: $269 · 2023: $27.16 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $218.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $157.79 | 2020 | |
| Carbofix Orthopedics INC | $155.08 | 2022-2025 | |
| Peerless Surgical INC. | $150.50 | 2025 | |
| Medical Device Business Services, INC. | $124.83 | 2019 | |
| Molli Surgical (US) INC | $78.65 | 2022 | |
| Integra Lifesciences Corporation | $75.84 | 2022 | |
| Stryker Corporation | $75.54 | 2019 | |
| Zimmer Biomet Holdings, INC. | $50.62 | 2020 | |
| Innovation Technologies INC | $27.16 | 2023 | Irrisept |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Leddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.